ENSG:NSD-The Ensign Group Inc (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 129.15

Change

0.00 (0.00)%

Market Cap

USD 7.42B

Volume

0.75M

Analyst Target

USD 62.50
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer. The Skilled Services segment provides short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; specialty care, such as on-site dialysis, ventilator care, cardiac, and pulmonary management; and standard services, such as room and board, special nutritional programs, social services, recreational activities, entertainment, and other services. The Standard Bearer segment leases post-acute care properties to healthcare operators. In addition, the company operates senior living units; and provides ancillary services consisting of digital x-ray, ultrasound, electrocardiograms, sub-acute services, dialysis, respiratory, and long-term care pharmacy and patient transportation to people in their homes or at long-term care facilities, as well as mobile diagnostics. The company was incorporated in 1999 and is based in San Juan Capistrano, California.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-02 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
OPCH Option Care Health Inc

N/A

USD 5.27B
SGRY Surgery Partners Inc

N/A

USD 3.06B
LFST Lifestance Health Group Inc

N/A

USD 3.03B
AMED Amedisys Inc

N/A

USD 3.02B
ACHC Acadia Healthcare Company Inc

N/A

USD 2.79B
ADUS Addus HomeCare Corporation

N/A

USD 1.74B
ASTH Astrana Health Inc

N/A

USD 1.21B
AVAH Aveanna Healthcare Holdings In..

N/A

USD 0.82B
HCSG Healthcare Services Group Inc

N/A

USD 0.78B
CCRN Cross Country Healthcare Inc

N/A

USD 0.55B

ETFs Containing ENSG

SAWS AAM Sawgrass U.S. Small C.. 2.52 % 0.00 %

N/A

USD 1.01M
OASC OneAscent Small Cap Core .. 0.91 % 0.00 %

N/A

USD 0.02B
CBUSAS:SW Amundi S&P SmallCap 600 E.. 0.85 % 0.00 %

N/A

N/A
RTWO:LSE L&G Russell 2000 US Small.. 0.55 % 0.00 %

N/A

USD 0.22B
RTWP:LSE Legal & General UCITS ETF.. 0.55 % 0.00 %

N/A

USD 0.22B
IWO iShares Russell 2000 Grow.. 0.00 % 0.24 %

N/A

N/A
OLD 0.00 % 0.50 %

N/A

N/A
OSCV Opus Small Cap Value Plus 0.00 % 0.79 %

N/A

USD 0.50B
KSCD 0.00 % 0.00 %

N/A

N/A
SLY 0.00 % 0.15 %

N/A

N/A
SLYG SPDR® S&P 600 Small Cap .. 0.00 % 0.15 %

N/A

N/A
VIOO Vanguard S&P Small-Cap 60.. 0.00 % 0.15 %

N/A

N/A
IDP6:LSE iShares S&P SmallCap 600 .. 0.00 % 0.00 %

N/A

N/A
IUS3:F iShares S&P Small Cap 600.. 0.00 % 0.00 %

N/A

N/A
ETLZ:XETRA L&G Russell 2000 US Small.. 0.00 % 0.00 %

N/A

USD 0.09B
IUS3:XETRA iShares S&P Small Cap 600.. 0.00 % 0.00 %

N/A

N/A
SMLE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.79% 58% F 44% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.79% 58% F 44% F
Trailing 12 Months  
Capital Gain 5.95% 85% B 63% D
Dividend Return 0.25% 100% F 3% F
Total Return 6.20% 85% B 59% D-
Trailing 5 Years  
Capital Gain 207.35% 100% F 92% A
Dividend Return 2.79% 50% F 6% D-
Total Return 210.14% 100% F 92% A
Average Annual (5 Year Horizon)  
Capital Gain 27.01% 78% C+ 79% B-
Dividend Return 27.29% 78% C+ 78% C+
Total Return 0.29% 50% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 38.60% 48% F 49% F
Risk Adjusted Return 70.72% 100% F 87% B+
Market Capitalization 7.42B 100% F 91% A-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.